About Ergos Life Sciences Private Limited
Data last updated:
Ergos Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Maneesh Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24303MH2017PTC292787. Its GSTIN is 27AAECE5764C1ZP (Maharashtra).
The company has an authorised share capital of ₹61 Cr and a paid-up capital of ₹61 Cr. It is led by directors Sakti Pada Chakraborty and Vinay Ramakant Sapte.
Its last annual general meeting (AGM) was held on 11 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹24.89 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹4.12 Cr (net margin -16.5%) and EBITDA of ₹70.34 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
The company has about 292 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 4 filed against it. The company has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 rights issue); the latest was in March 2019. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Pyxus Pharmaceuticals Private Limited with revenue of ₹24.91 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 200 overdue payments to 9 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ergoslife.com.
Company details
Contact details
Ergos Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is ergoslife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 29 To 33 Ancillary, Industrail Plots Govandi, Mumbai, Maharashtra, India – 400043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ergos Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ergos Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ergos Life Sciences Private Limited, buy the company report.
Financials of Ergos Life Sciences Private Limited
FY 2023 filings availableErgos Life Sciences Private Limited reported revenue of ₹24.89 Cr (down 2% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 2% fall in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | -16.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ergos Life Sciences Private Limited, buy the company report.
Board of directors of Ergos Life Sciences Private Limited
Ergos Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sakti Pada Chakraborty Also directs: Sanzio Lifesciences Private Limited | Director | 01 Apr 2017 | 9 Years 6 Months | Current |
| Vinay Ramakant Sapte Also directs: Svizera Health Remedies LLP, Mantech Counting and Systems LLP, Adhrit Education LLP and 5 more | Director | 21 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Ergos Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pyxus Pharmaceuticals Private Limited | ₹24.91 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Accusynth Speciality Chemicals Private Limited | ₹24.9 Cr (FY 2020) | -25.0% | Mumbai, Maharashtra, India | |||
| 3Ak Chemie Private Limited | ₹24.9 Cr (FY 2024) | 33.0% | Hyderabad, Telangana, India | |||
| R.B. Dyechem Private Limited | ₹24.89 Cr (FY 2024) | 1.0% | Aligarh, Uttar Pradesh, India | |||
| Sahaj Cerchem Private Limited | ₹24.89 Cr (FY 2025) | 6.0% | Uttar Pradesh, India | |||
| Ergos Life Sciences Private Limitedthis company | ₹24.89 Cr (FY 2022) | -₹4.12 Cr | -16.5% | -2.0% | 292 | Mumbai, Maharashtra, India |
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | 37.0% | Chennai, Tamil Nadu, India | |||
| Tejas Rasayan Private Limited | ₹24.87 Cr (FY 2024) | -17.0% | New Delhi, Delhi, India | |||
| Tara Mercantile Private Limited | ₹24.87 Cr (FY 2025) | -8.0% | Delhi, India | |||
| Sumit Pharmaceuticals Private Limited | ₹24.86 Cr (FY 2025) | 34.0% | Lucknow, Uttar Pradesh, India | |||
| Everest Fertilizers and Chemicals Pvt Ltd | ₹24.84 Cr (FY 2025) | 88.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Ergos Life Sciences Private Limited, buy the company report.
Auditor
Ergos Life Sciences Private Limited is audited by KAUSHAL MANISH & COMPANY for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAUSHAL MANISH & COMPANY | FY 2021 | 125710W |
Shareholding
The shareholding of Ergos Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ergos Life Sciences Private Limited, buy the company report.
Deals & funding
Ergos Life Sciences Private Limited has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 rights issue); the latest was in March 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2019 | Rights issue | ₹25 Cr | Investors: Maneesh Pharmaceuticals Limited |
| Aug 2017 | Acquisition | ₹35 Cr | Buyer: Maneesh Pharmaceuticals Limited |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ergos Life Sciences Private Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed against the company by Maxcure Nutravedics Ltd | Disposed |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed against the company by Akums Drugs and Pharmaceuticals Pvt Ltd | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Disposed |
To see the full case history of Ergos Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ergos Life Sciences Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 200 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Printania Offset Private Limited | |||
| Ambassador Express Holidays Private Limited | |||
| Universal Pharmaceuticals Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Ergos Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ergos Life Sciences Private Limited has a workforce of 292 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Ergos Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE5764C1ZP | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ergos Life Sciences Private Limited, buy the company report.
Recent activity
Ergos Life Sciences Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Sanyukta Chakraborty ceased to be Director on 03 Aug 2017.
Frequently asked questions
Ergos Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2017 (9+ years old) and is registered under CIN U24303MH2017PTC292787.
Ergos Life Sciences has 2 current directors:
- Sakti Pada Chakraborty - Director
- Vinay Ramakant Sapte - Director
The latest financial statements of Ergos Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 July 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ergos Life Sciences is 27AAECE5764C1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ergos Life Sciences is U24303MH2017PTC292787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ergos Life Sciences has 4 court cases on record: 4 filed against it.
Ergos Life Sciences was incorporated on 21 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Ergos Life Sciences has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 rights issue); the latest was in March 2019.
The peers of Ergos Life Sciences by revenue are Pyxus Pharmaceuticals Private Limited, Accusynth Speciality Chemicals Private Limited, 3Ak Chemie Private Limited, R.B. Dyechem Private Limited, Sahaj Cerchem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanyukta Chakraborty ceased to be Director on 03 Aug 2017. Sakti Pada Chakraborty ceased to be Additional Director on 10 Apr 2017. Sakti Pada Chakraborty was appointed as Director on 01 Apr 2017. Ergos Life Sciences has 4 board changes on record in total.
Ergos Life Sciences has 5 MSME Form 1 returns on record between 2019 and 2022, listing 200 overdue payments to 9 micro and small suppliers. The latest return was filed on 21 Apr 2022.
Ergos Life Sciences can be reached through the website ergoslife.com. Its registered office is in Mumbai, Maharashtra, India.